Monday, September 15th, 2025

China Sunsine Chemical Holdings Ltd. Announces Dividend Payment Details

China Sunsine Chemical Holdings Announces Attractive Dividends for Shareholders
Highlights:
China Sunsine Chemical Holdings Ltd. has announced a final (one-tier tax exempt) dividend of 2.0 Singapore cents per ordinary share and a final (one-tier tax exempt) special dividend of 1.0 Singapore cent per ordinary share for the financial year ended 31 December 2024.
The dividends are subject to shareholders’ approval at the upcoming Annual General Meeting on 29 April 2025.
The company’s share transfer books and register of members will be closed on 8 May 2025 to determine shareholders’ entitlement to the dividends.
Shareholders whose securities accounts are credited with the company’s shares as of 5.00 p.m. on the record date of 8 May 2025 will be entitled to the dividends.
If approved, the dividends will be paid on 22 May 2025.
Potential Impact: The announcement of the attractive dividends is likely to be well-received by investors and could potentially have a positive impact on the company’s share price. Shareholders who are entitled to the dividends may see an increase in their investment returns, which could make the stock more attractive to both existing and potential investors.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and due diligence before making any investment decisions. The author and the publication do not guarantee the accuracy or completeness of the information provided, and shall not be held responsible for any actions taken based on the information presented.

View ChinaSunsine Historical chart here



Credit Bureau Asia Limited Responds to SIAS Queries on Annual Report and Operations

Credit Bureau Asia Limited Responds to SIAS Queries: Key Updates and Insights Credit Bureau Asia Limited (the “Company”) has addressed queries from the Securities Investors Association Singapore (“SIAS”) regarding its annual report for the...

Clearbridge Health Announces S$2.56 Million Rights Issue to Strengthen Financial Position and Fuel Growth

Clearbridge Health’s Massive Rights Issue: A Game-Changer for Shareholders? Clearbridge Health’s Massive Rights Issue: A Game-Changer for Shareholders? Clearbridge Health Limited has announced a significant financial maneuver with its proposed renounceable non-underwritten rights issue,...

CSE Global Reports 15.4% Revenue Growth in Q3 2024 Despite Market Uncertainties

CSE Global Reports Strong Revenue Growth Amid Market Challenges CSE Global Reports Strong Revenue Growth Amid Market Challenges Singapore-based CSE Global Limited has announced its interim business updates for the third quarter of 2024,...